BIRC5 and breast cancer: The levels of BIRC5/Survivin, expressed in most human cancers, but absent in normal tissues, and shown to promote proliferation and inhibition of apoptosis of cancer cells including BC [32,33], were also significantly reduced by DLL1 downregulation (2-fold).